Ledger.Open graph →
SEC Form D · Amendment · filed March 20, 2020

CerSci Therapeutics Inc

Offering
$12.0M
Sold
$12.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
DALLAS, TX
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Lucas Rodriguez · Dallas, TXExec · DirectorBrent Duncan · Lewisville, TXDirectorGeorge Schaeffer · San Francisco, CAExec · DirectorPerry Molinoff · Exton, PADirectorJohn D. Harkey, Jr · Dallas, TXDirectorPat Confalone · Wilmington, DEDirectorDennis Robbins · Richardson, TXDirectorDavid Hitt Ii · Plano, TXDirectorDavid Genecov · Dallas, TXDirectorScott Dax · Landenberg, PADirectorTyler Brous · Dallas, TXDirectorVinay Nair · Boulder, COExec · DirectorPerry Molinoff · Johns Island, SCDirectorJohn D. Harkey, Jr · Dallas, TXDirectorBrent Duncan · Lewisville, TXDirectorPat Confalone · Wilmington, DEDirectorDennis Robbins · Richardson, TXDirectorDavid Hitt Ii · Plano, TXDirectorDavid Genecov · Dallas, TXDirectorScott Dax · Landenberg, PADirectorTyler Brous · Dallas, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗